SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 2020

AgenT-797, a novel allogenic and “off-the shelf” iNKT cell therapy promotes effective tumor killing, B. Yigit, et al.

Poster •November 11 - 14, 2020

SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 2019

Discovery and characterization of the first fully-human Phosphopeptide Tumor Target-specific T cell receptor, X. Michelet, et al.

Poster •November 7 - 10, 2019

Invariant natural killer T cells as an allogeneic cell therapy platform, B. Yigit, et al.

Poster •November 7 - 10, 2019